OHSU Knight Cancer Institute Research Groups:OCI Research Group Meetings

Home        Faculty        Graduate Program        Postdocs        OHSU Knight Core Facilities       

Programs     Res Group Meetings        Cancer Journal Club        Cell/CANB 616        Gen. Inst/R3 Club     CANB 610    

Objectives of the OHSU Knight Cancer Biology Research Group Meetings

Cross-departmental workshop composed of students, postdocs, and faculty with shared interest in basic principles and emerging discoveries in Cancer Biology. The goals of the meetings and this wiki:

• Establish a challenging and interactive cross-departmental focus group that will advance understanding of our individual projects and encourage collaborations.
• Provide students and postdocs with training and interactions with faculty interested in Cancer Biology and emerging therapeutics

These meetings are now expanded to include a Translational Cancer Research Group Meeting. The purpose of this meeting is to:

• Serve to foster a Knight translational research incubator for projects and teams leading to multi-investigator cancer program/SPORE funding including the Solid tumors and Hematologic Malignancies programs and the Systems Biology group.
• Meetings will include thematic research and clinical research talks with collaborative and developmental potential and Brainstorming Sessions.

Knight Research Group Activities

Want to join us? All are invited!

To get on the listserve:

go to the following web site:

http://mailman.ohsu.edu/cgi-bin/mailman/listinfo/oncres

follow the instructions for subscribing

• We meet in the Knight Conference Room 14th floor Hatfield Research Bldg

Fridays 9:15-10:15 AM - see schedule below

Breakfast provided by the Knight!

• Organizer: Rosie Sears, email searsrATohsu.edu
• Translational meeting organizer: Molly Kulesz-Martin, email kuleszma@ohsu.edu

Member Labs and Affiliations

Lopez Lab Hem Onc

Sears Lab, MMG

Hoatlin Lab, BMB

Thayer Lab, BMB

Lloyd Lab, CROET

McCullough Lab, CROET

Wong Lab, Dermatology, CDB

Zundel Lab, Radiation Medicine, Cancer Biology

Spindel Lab, Primate Center, NGP, Cancer Biology

• Add your lab here

Schedule

*Red indicates Translational Cancer Research Group Meetings

Date	Presenters	Topic	Links & Comments	Location
9/23/2011	Thomas Jacob	Fluorescent quantum dot nanoparticle technology for molecular assessment of oncogenic kinase signaling	Dr. Tania Vu’s lab in biomedical engineering
10/7/2011	Brett Sheppard	Pancreatic Cancer- Setting the Stage
10/14/2011	Eliot Spindel	Targeting cholinergic signaling in lung cancer	Dr. Eliot Spindel's lab: Neuroscience meets lung cancer and lung development
10/21/2011	Soren Impey	Pancreas
10/28/2011
11/4/2011	Philip Streeter	Pancreas: Immunoassays for Detection of Early Pancreatic Cancer
11/11/2011	Joe Gray	Pancreas: “Subtyping pancreatic cancers – advancing diagnosis and treatment”
11/18/2011	Fox Lab	Pancreas
12/2/2011	Rosie Sears	Pancreas:
12/9/2011	Charles Springer	Can MRI Map the Angiogenic Switch in Human Breast Tumors in Vivo?
12/16/2011		Pancreas: Brain Storming
1/6/2012	CANCELLED
1/13/2012	Steve Chui Shiuh-Wen Luoh	Breast Cancer: I-Spy-2 and tissue collection
1/20/2012	Megan Troxell	Breast Cancer: Pathologist PI3K mutations in early breast cancer lesions
1/27/2012	Joshi Alumkal	Thinking Outside the (Androgen) Box in Prostate Cancer
2/3/2012	Rosie Sears Jim Korkola	Breast Cancer: Korkola: Combination Therapies and Irreversible Inhibitors for the treatment of HER2 positive breast cancer; Sears: Strategies to target c-Myc in breast cancer
2/10/2012	Steven Jacques	Label-free optical imaging of cellular processes
2/17/2012	Lisa Coussens	Breast Cancer:Inflammation and Breast Cancer: Targeting Macrophages to Enhance Chemotherapy
2/24/2012	George Thomas	Re-thinking Targeted Therapies for Kidney Cancer
3/2/2012	Juha Rantala Koei Chin	Breast Cancer (Rantala): Targeted RNAi screens in breast cancer cells using cell spot microarrays. Breast Cancer (Chin): Omics Analysis in Breast Cancer: Genome to Protein
3/9/2012	Daniel Marks	Brain Mechanisms in Cancer Cachexia
3/16/2012	Xiangshu Xiao	Breast Cancer: Small Molecules Targeting CREB for Breast Cancer Therapy
3/23/2012	Canceled for the 2012 BioMedicine in 4D Conference	[1]
3/30/2012	NO MEETING	Spring Break
4/6/2012	Allen Ebens, PhD	Genentech	***Note the location change ***	MAC HALL 2201
4/13/2012	Jen Vomaske		***Note the location change ***	MAC HALL 2201
4/20/2012	Wassana Yantasee Zhi Hu	Part I. Optimization of therapeutic siRNA against HER2 (Hu) Part II. Nanoparticle platform for siRNA delivery and HER2 silencing (Yantasee)	***Note the location change ***	MAC HALL 2201
4/27/2012	Lucia Carbone	Mechanisms of chromosomal rearrangement in evolution and cancer	***Note the location change ***	MAC HALL 2201
5/4/2012	Joe Gray	Breast Cancer: Prospects for interrogating the signaling nanostructure of breast cancer	***Note the location change ***	MAC HALL 2201
5/11/2012	Wong Lab (Nick Smith, Emily Bubbers)		***Note the location change ***	MAC HALL 2201
5/18/2012	John Muschler Sunjong Kwon	Breast Cancer	***Note the location change ***	MAC HALL 2201
5/25/2012	Liskay Lab	Modelling Sporadic Intestinal Cancer	***Note the location change ***	MAC HALL 2201
6/1/2012	Paul Spellman	Breast Cancer:Genomic Analysis of Breast Cancers. Beyond TCGA	***Note the location change ***	MAC HALL 2201
6/8/2012	Kinrin Yamanaka (Dr. Stephen Lloyd lab)	The identification of small molecule inhibitors of DNA polymerase kappa	***Note the location change ***	MAC HALL 2201
6/15/2012	Brainstorming	Breast Cancer	***Note the location change ***	MAC HALL 2201
6/22/2012	Neil Osheroff	Vanderbilt	***Note the location change ***	MAC HALL 2201
6/29/2012	Jay Nelson	Proteomic and genomics in the PNWRCE: a forum for infectious diseases applications to cancer	***Note the location change ***	MAC HALL 2201